Skip to content

Utility evaluation of AI based Mobile Refractor for Early Diagnosis of Childhood Refractive Error and Amblyopia Risk: Comparison of Domestic Medical Device with Overseas Multiple Devices

Evaluation of the usability of mobile-based optometry for early diagnosis of refractive error and amblyopia risk

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0004275
Enrollment
500
Registered
2019-09-04
Start date
2019-11-11
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Photoscreening test by Kizopter(PD-01), Spot PediaVision(VS100S-2),PlusoptixA12(Plusoptix 12C(A-type)

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) age between 2 and 8 years old 2) who needs a photorefraction test 3) who voluntarily agrees to this study

Exclusion criteria

Exclusion criteria: 1) if they had eccentric fixation, optical media opacity, or the refractive errors of the eyes did not exceed a maximum limits of devices. 2) systemic or ocular pathology such as strabismus, glaucoma, cataract, or ocular surface disease, and not having previous ocular surgery

Design outcomes

Primary

MeasureTime frame
The comparison to conformity degree of MR, CR and Photoscreeners(Kizopter, Sopt Pediavision, PlusoptixA12)

Secondary

MeasureTime frame
The comparison to sensitivity, sepcificity, drop out ration of Photoscreeners(Kizopter, Sopt Pediavision, PlusoptixA12)

Countries

Korea, Republic of

Contacts

Public ContactDong hui Lim

Samsung Medical Center

ku.hwang@samsung.com+82-2-3410-5478

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026